Massivemarkets

SEC Form 4

Colgate-Palmolive Company (CL) insider trading

In the 12 months to Oct 24, 2026, 8 CL insiders reported open-market sales of $57.1M across 13 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$57.1M
13 filings · 8 insiders
Open-market purchases
$0
0 filings

Who traded CL, and when

  • Sale

CL daily close from Oct 24, 2025 to Oct 23, 2026, between $74.98 and $99.14, last $94.04. 13 sale and 0 purchase filings by 8 insiders, marked at their filing dates. Noel R. Wallace, Chairman, President & CEO: sold $34.0M across 2 filings, first filed Feb 6, 2026, last Aug 6, 2026. Stanley J. Sutula III, Chief Financial Officer: sold $9.2M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. Panagiotis Tsourapas, COO, Eur., APac, Afr Eur, Skin → COO, CD, EMEA, APac, Skin: sold $5.7M across 2 filings, first filed Feb 13, 2026, last Aug 26, 2026. Sally Massey, Chief Human Resources Officer → Chief People Officer: sold $2.4M across 3 filings, first filed Nov 24, 2025, last May 11, 2026. Jennifer Daniels, CLO and Secretary: sold $2.1M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. John Hazlin, Chief Growth Officer: sold $2.0M across 1 filing, first filed Feb 12, 2026, last Feb 12, 2026. 2 others: sold $1.8M across 3 filings, first filed Feb 10, 2026, last Aug 7, 2026.

Largest mark · tap a row for others

Noel R. Wallace · Chairman, President & CEO

Sale $29,698,617

322,042 shares at $92.22 avg

Filed Aug 6, 2026 · traded Aug 4

Close on filing date $93.00

CL daily closelast $94.04

Noel R. Wallace · Chairman, President & CEO

$34.0M sold

Stanley J. Sutula III · Chief Financial Officer

$9.2M sold

Panagiotis Tsourapas · COO, Eur., APac, Afr Eur, Skin → COO, CD, EMEA, APac, Skin

$5.7M sold

Sally Massey · Chief Human Resources Officer → Chief People Officer

$2.4M sold

Jennifer Daniels · CLO and Secretary

$2.1M sold

John Hazlin · Chief Growth Officer

$2.0M sold

2 others

$1.8M sold
One row per insider, smaller filers combined; marks sit at the SEC filing date, sized by dollar value.

Has the Colgate-Palmolive Company's CEO sold stock?

Yes. Noel R. Wallace (CEO) sold 367,610 shares ($34.0M) between Feb 2026 and Aug 2026.

Open-market trades

13 filings in the last 12 months
InsiderRoleSoldBoughtFilingsPre-arranged (10b5-1)Last filed
Noel R. WallaceChairman, President & CEO$34.0M—2—
Stanley J. Sutula IIIChief Financial Officer$9.2M—1—
Panagiotis TsourapasCOO, Eur., APac, Afr Eur, Skin → COO, CD, EMEA, APac, Skin$5.7M—2—
Sally MasseyChief Human Resources Officer → Chief People Officer$2.4M—3—
Jennifer DanielsCLO and Secretary$2.1M—1—
John HazlinChief Growth Officer$2.0M—1—
Gregory MalcolmEVP and Controller$1.4M—2—
John T. CahillDirector$389.4K—1—
Other insider activity (not market trades) · 82 records
  • Option exercises10 records
  • Tax withholding36 records
  • Grants and awards36 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

Build this yourself

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Agent prompt

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CL every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Role
The title on each filing. Someone whose title changed shows more than one.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.